Next Article in Journal
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia
Next Article in Special Issue
Lung-Targeted Delivery of Cepharanthine by an Erythrocyte-Anchoring Strategy for the Treatment of Acute Lung Injury
Previous Article in Journal
Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?
Previous Article in Special Issue
Evaluation of the Cytotoxic, Anti-Inflammatory, and Immunomodulatory Effects of Withaferin A (WA) against Lipopolysaccharide (LPS)-Induced Inflammation in Immune Cells Derived from BALB/c Mice
 
 
Article
Peer-Review Record

Cinnamic Acid Attenuates Peripheral and Hypothalamic Inflammation in High-Fat Diet-Induced Obese Mice

Pharmaceutics 2022, 14(8), 1675; https://doi.org/10.3390/pharmaceutics14081675
by Aden Geonhee Lee 1,†, Sora Kang 2,†, Suyeol Im 2 and Youngmi Kim Pak 2,3,*
Reviewer 1:
Reviewer 2: Anonymous
Reviewer 3:
Pharmaceutics 2022, 14(8), 1675; https://doi.org/10.3390/pharmaceutics14081675
Submission received: 28 June 2022 / Revised: 2 August 2022 / Accepted: 9 August 2022 / Published: 11 August 2022

Round 1

Reviewer 1 Report

In this study, Lee et al examined the effects of cinnamic acid (CA) in obesity-induced metabolic changes and inflammatory mediators using a high fat diet-fed mouse model. The authors found that CA ameliorated HFD-induced epididymal fat gain, insulin resistance, glucose tolerance and dyslipidemia without adverse effects. Macrophage infiltration in liver and adipose tissue as well as HFD-induced inflammatory mediators such as TNF-alpha in blood, adipose tissue and the liver, were also decreased when mice were treated with CA, suggesting CA as a potential therapeutic for obesity-related metabolic disorders. The manuscript is well written, though it requires minor grammatical error checks. Their observations are interesting and reports out significant findings, but lack complete mechanistic understanding.  I have following comments that are recommended to be addressed before considering for publication.

1)    It is not clear how does CA suppress macrophage and monocyte infiltration in HFD-induced mice? The authors also need to discuss how reduced inflammatory response leads to improve insulin resistance, glucose intolerance and lipid metabolism.

2)    What are the signaling cascades that CA utilizes to exert anti-obesity or anti-inflammatory effects?

3)    It is unclear how did authors decide dosages of CA in their treatment regimen.

4)    How is CA relevant in clinical setting for the treatment of female patients suffering from such metabolic disorders?

5)    HFD-fed mice is known to develop severe nephropathy. It would be interesting to see histological analysis of kidney sections demonstrating the degrees of glomerulosclerosis and tubular injury in CA-treated vs untreated mice.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

Accept in current form 

Author Response

Thank you.

Reviewer 3 Report

This is a well designed and solid study. The authors investigated the active compounds in Cinnamon that have beneficial effect on high fat diet induced obesity. They used both computation and animal models to show that Cinnamic acid ameliorates HFD induced obesity and inflammation. The results are clearly presented and easy to understand. The data support their conclusions.  

Author Response

Thank you for your nice comment.

Round 2

Reviewer 1 Report

Overall, the authors have improved the manuscript and presented and discussed the results in clearer manner.

Back to TopTop